BILL ANALYSIS

 

 

Senate Research Center

S.B. 2003

84R12080 LED-D

By: Eltife; Garcia

 

Business & Commerce

 

4/2/2015

 

As Filed

 

 

 

AUTHOR'S / SPONSOR'S STATEMENT OF INTENT

 

Women with ovarian cancer face a high mortality rate largely because the disease has vague symptoms and the manifestation of the disease is not recognized until it is too late. This is compounded by the circumstance that women are not regularly screened for the disease in the same manner as for cervical cancer and breast cancer. These factors result in the disease being diagnosed almost always at an advanced stage, making it very difficult to successfully treat.

 

Early detection and intervention can significantly increase the odds of permanent remission. The CA 125 blood test is a promising diagnostic tool, especially when used in conjunction with an ultrasound if the CA 125 is found to be elevated, indicating the possible presence of ovarian cancer.

 

S.B. 2003 addresses these concerns by improving ovarian cancer screening practices. The bill amends Chapter 1370, Insurance Code, to add ovarian cancer as a detection test.

 

As proposed, S.B. 2003 amends current law relating to health benefit plan coverage for ovarian cancer screening.

 

RULEMAKING AUTHORITY

 

This bill does not expressly grant any additional rulemaking authority to a state officer, institution, or agency.

 

SECTION BY SECTION ANALYSIS

 

SECTION 1. Amends the heading to Chapter 1370, Insurance Code, to read as follows:

 

CHAPTER 1370. CERTAIN TESTS FOR DETECTION OF HUMAN PAPILLOMAVIRUS, OVARIAN CANCER, AND CERVICAL CANCER

 

SECTION 2. Amends Sections 1370.003(a) and (b), Insurance Code, as follows:

 

(a) Requires that a health benefit plan that provides coverage for diagnostic medical procedures provide to each woman 18 years of age or older enrolled in the plan coverage for expenses for an annual medically recognized diagnostic examination for the early detection of ovarian cancer and cervical cancer.

 

(b) Requires that coverage required under this section includes at a minimum:

 

(1) a CA 125 blood test; and

 

(2) Creates this subdivision from existing text. Makes no further change to this subdivision.

 

SECTION 3. Provides that the change in law made by this Act applies only to a health benefit plan that is delivered, issued for delivery, or renewed on or after the effective date of this Act. Makes application of this Act prospective.

 

SECTION 4. Effective date: September 1, 2015.